TrialAnnals of oncology : official journal of the European Society for Medical Oncology2014

A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib.

K N Ganjoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.